- Home
- BNTX vs VOD Comparison
BNTX vs VOD Comparison
Compare BNTX & VOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- VOD
- Stock Information
- Founded
- BNTX 2008
- VOD 1984
- Country
- BNTX Germany
- VOD United Kingdom
- Employees
- BNTX N/A
- VOD N/A
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- VOD Telecommunications Equipment
- Sector
- BNTX Health Care
- VOD Telecommunications
- Exchange
- BNTX Nasdaq
- VOD Nasdaq
- Market Cap
- BNTX 23.9B
- VOD 22.6B
- IPO Year
- BNTX 2019
- VOD 1988
- Fundamental
- Price
- BNTX $118.84
- VOD $9.06
- Analyst Decision
- BNTX Strong Buy
- VOD
- Analyst Count
- BNTX 14
- VOD 0
- Target Price
- BNTX $141.60
- VOD N/A
- AVG Volume (30 Days)
- BNTX 1.1M
- VOD 7.0M
- Earning Date
- BNTX 11-04-2024
- VOD 11-12-2024
- Dividend Yield
- BNTX N/A
- VOD 7.85%
- EPS Growth
- BNTX N/A
- VOD N/A
- EPS
- BNTX N/A
- VOD 0.11
- Revenue
- BNTX $3,390,698,192.00
- VOD $41,278,161,929.00
- Revenue This Year
- BNTX N/A
- VOD $6.34
- Revenue Next Year
- BNTX N/A
- VOD $1.74
- P/E Ratio
- BNTX N/A
- VOD $8.07
- Revenue Growth
- BNTX N/A
- VOD 5.15
- 52 Week Low
- BNTX $76.53
- VOD $8.02
- 52 Week High
- BNTX $131.49
- VOD $10.39
- Technical
- Relative Strength Index (RSI)
- BNTX 57.73
- VOD 50.49
- Support Level
- BNTX $101.02
- VOD $8.76
- Resistance Level
- BNTX $121.80
- VOD $9.03
- Average True Range (ATR)
- BNTX 5.10
- VOD 0.11
- MACD
- BNTX 0.95
- VOD 0.04
- Stochastic Oscillator
- BNTX 89.23
- VOD 86.05
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
About VOD Vodafone Group Plc
Vodafone operates mobile and fixed-line networks and businesses in more than 20 countries. Its largest market is Germany, where it is the second mobile operator after Deutsche Telekom and owns a cable network after acquiring Kabel Deutschland in 2013 and Liberty Global Germany in 2019. In the UK it acts as a mobile operator and is attempting a merger with CK Hutchison as of 2024. In 2024 Vodafone also divested its Spanish and Italian divisions, given their low returns on invested capital.